Feng et al11 identified ARID1A as a prognostic biomarker associated with immune infiltrates in HCC: high ARID1A expression was associated with worse prognosis and low immune cell infiltration; decreasing ARID1A expression inhibited cell cycle, proliferation, migration, and invasion in HCC. Here, ARID1A is linked to hepatocellular carcinoma.